2010
How Can We Communicate About Vaccines With Adolescents and Their Parents?
Benin AL, Wu AC, Holmboe ES, Shapiro ED, Anyan W. How Can We Communicate About Vaccines With Adolescents and Their Parents? Clinical Pediatrics 2010, 49: 373-380. PMID: 20118100, PMCID: PMC3773171, DOI: 10.1177/0009922809351091.Peer-Reviewed Original Research
2004
Invasive Pneumococcal Disease among Navajo Adults, 1989–1998
Watt J, O'Brien K, Benin A, Whitney C, Robinson K, Parkinson A, Reid R, Santosham M. Invasive Pneumococcal Disease among Navajo Adults, 1989–1998. Clinical Infectious Diseases 2004, 38: 496-501. PMID: 14765341, DOI: 10.1086/381198.Peer-Reviewed Original ResearchConceptsInvasive pneumococcal diseaseNavajo adultsPneumococcal diseaseEpidemiology of IPDRates of IPDPneumococcal polysaccharide vaccineCase fatality rateGeneral US populationPercent of casesBlack personsPolysaccharide vaccineAnnual incidenceActive surveillanceMedical recordsElevated riskPrevention strategiesUS populationDiseaseCorresponding ratesAdditional researchAdultsUnited StatesRiskPatientsVaccine
2003
Effectiveness of the 23-Valent Polysaccharide Vaccine against Invasive Pneumococcal Disease in Navajo Adults
Benin AL, O'Brien KL, Watt JP, Reid R, Zell ER, Katz S, Donaldson C, Parkinson A, Schuchat A, Santosham M, Whitney CG. Effectiveness of the 23-Valent Polysaccharide Vaccine against Invasive Pneumococcal Disease in Navajo Adults. The Journal Of Infectious Diseases 2003, 188: 81-89. PMID: 12825175, DOI: 10.1086/375782.Peer-Reviewed Original ResearchConceptsInvasive pneumococcal diseaseOverall vaccine effectivenessNavajo adultsPneumococcal diseaseCase patientsControl patientsPolysaccharide vaccineVaccine effectivenessGeneral United States populationSerious pneumococcal diseasePneumococcal polysaccharide vaccineCohort methodologyUnited States populationCase-control setsActive surveillanceObservational studyMedical conditionsPatientsMedical careDiseaseAdultsDiabetesRegression analysisVaccineAlcoholism